These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10180920)

  • 1. A model of the impact of reimbursement schemes on health plan choice.
    Keeler EB; Carter G; Newhouse JP
    J Health Econ; 1998 Jun; 17(3):297-320. PubMed ID: 10180920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency.
    van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    J Health Econ; 2001 Mar; 20(2):147-68. PubMed ID: 11252368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands.
    Lamers LM; van Vliet RC; van de Ven WP
    Health Policy; 2003 Jul; 65(1):49-62. PubMed ID: 12818745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managed competition and consumer price sensitivity in social health insurance.
    Schut FT; Hassink WH
    J Health Econ; 2002 Nov; 21(6):1009-29. PubMed ID: 12475123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk adjustment in Switzerland.
    Beck K; Spycher S; Holly A; Gardiol L
    Health Policy; 2003 Jul; 65(1):63-74. PubMed ID: 12818746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A demand-side view of risk adjustment.
    Feldman R; Dowd BE; Maciejewski M
    Inquiry; 2001; 38(3):280-9. PubMed ID: 11761355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimbursing insurance carriers: the case of 'MUFACE' in the Spanish health care system.
    Pellisé L
    Health Econ; 1994; 3(4):243-53. PubMed ID: 7994324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk adjustment and risk sharing: the Israeli experience.
    Shmueli A; Chernichovsky D; Zmora I
    Health Policy; 2003 Jul; 65(1):37-48. PubMed ID: 12818744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumer price sensitivity in Dutch health insurance.
    van Dijk M; Pomp M; Douven R; Laske-Aldershof T; Schut E; de Boer W; de Boo A
    Int J Health Care Finance Econ; 2008 Dec; 8(4):225-44. PubMed ID: 18709549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring adverse selection in managed health care.
    Frank RG; Glazer J; McGuire TG
    J Health Econ; 2000 Nov; 19(6):829-54. PubMed ID: 11186848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk adjustment: where are we now?
    Newhouse JP
    Inquiry; 1998; 35(2):122-31. PubMed ID: 9719781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse selection and generosity of alcohol treatment benefits.
    Harris KM; Sturm R
    Inquiry; 2002-2003 Winter; 39(4):413-28. PubMed ID: 12638715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity-based payment methodology for Medicaid enrollees with HIV/AIDS.
    Fakhraei SH; Kaelin JJ; Conviser R
    Health Care Financ Rev; 2001; 23(2):53-68. PubMed ID: 12500338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belgium: risk adjustment and financial responsibility in a centralised system.
    Schokkaert E; Van de Voorde C
    Health Policy; 2003 Jul; 65(1):5-19. PubMed ID: 12818742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demand for a Medicare prescription drug benefit: exploring consumer preferences under a managed competition framework.
    Cline RR; Mott DA
    Inquiry; 2003; 40(2):169-83. PubMed ID: 13677564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulating the effects of employer contributions on adverse selection and health plan choice.
    Marquis MS; Buchanan JL
    Health Serv Res; 1999 Oct; 34(4):813-37. PubMed ID: 10536972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling individual health care expenditures in China: Evidence to assist payment reform in public insurance.
    Shi J; Yao Y; Liu G
    Health Econ; 2018 Dec; 27(12):1945-1962. PubMed ID: 30044018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How profitable is risk selection? A comparison of four risk adjustment models.
    Shen Y; Ellis RP
    Health Econ; 2002 Mar; 11(2):165-74. PubMed ID: 11921314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk adjustment of capitation payments to behavioral health care carve-outs: how well do existing methodologies account for psychiatric disability?
    Ettner SL; Frank RG; Mark T; Smith MW
    Health Care Manag Sci; 2000 Feb; 3(2):159-69. PubMed ID: 10780284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing imperfect competition by pay for performance and reference pricing.
    Mak HY
    J Health Econ; 2018 Jan; 57():131-146. PubMed ID: 29274520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.